Advertisement

Topics

Companies Related to "Innovate Biopharma Pediatric Ulcerative Colitis Drug Granted Orphan" [Most Relevant Company Matches] RSS

04:42 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Innovate Biopharma Pediatric Ulcerative Colitis Drug Granted Orphan" found in our extensive corporate database of over 50,000 company records.

Showing "Innovate Biopharma Pediatric Ulcerative Colitis Drug Granted Orphan" Companies 1–25 of 4,000+

Relevant

Atlantic Healthcare plc

Atlantic Healthcare is an international specialty pharmaceutical company focussed on diseases of the gastrointestinal tract and Inflammatory Bowel Disease (IBD). The Company's lead product is alicaforsen enema, in Phase 3 development for pouchitis, and in preparation for Phase 3 clinical development for Ulcerative Colitis. Alicaforsen is also generating ea...


RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundatio...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...


Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) is dedicated to alleviating the burden of patients suffering from autoimmune diseases by developing novel immunotherapeutic agents. Immune's lead product candidate, bertilimumab, is in Phase 2 clinical development for bullous pemphigoid, an orphan autoimmune dermatological condition, and for ulcerative colitis. Oth...

Atlantic Healthcare

Atlantic Healthcare is an international specialty pharmaceutical company focussed on diseases of the gastrointestinal tract and Inflammatory Bowel Disease (IBD). The Company's lead product is alicaforsen enema, in Phase 3 development for pouchitis, and in preparation for Phase 3 clinical development for Ulcerative Colitis. Alicaforsen is also generating ea...

AcuityBio Inc. and Cook Biotech Inc.

AcuityBio has developed a platform technology for localized, sustained, safe drug-delivery to be used in the prevention of post-surgical lung cancer recurrence. ABC103 combines approved/ cleared surgical staple-line buttress, drug eluting polymers and a chemotherapeutic drug, paclitaxel). ABC103 has been granted US FDA orphan drug designation for this indi...

ImproveCareNow

ImproveCareNow is a not-for-profit alliance of health care providers (including physicians, researchers, nurses, quality improvement experts, statisticians, data processing experts and administrators), patients and families all dedicated to helping children and adolescents with Crohn's disease and ulcerative colitis.

Akaal Pharma Pty Ltd.

Akaal Pharma Pty Ltd (Akaal Pharma) is a clinical-stage drug discovery and development company focused on the development of novel small molecule drugs for the treatment of inflammatory and autoimmune diseases including psoriasis, atopic dermatitis, multiple sclerosis, ulcerative colitis, and rheumatoid arthritis. Akaal Pharma has created a robust pipeline...

Gentium S.p.A.

Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the development and manufacture of drugs to treat and prevent a variety of diseases and conditions, including vascular diseases related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan ...

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

Crohn's & Colitis Foundation of America

The Crohn's & Colitis Foundation of America is the largest non-profit, volunteer-driven organization dedicated to finding a cure for Crohn's disease and ulcerative colitis, and it ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with approximately 79 cents of every dollar the Foundation spends going to mission-critical programs. The organ...

Orphan Europe (UK) Ltd.

Orphan Europe was started with the objective of providing orphan drugs to patients afflicted by rare disorders.Over the years an information network has been established to increase the awareness about rare disorders among healthcare professionals. The company has committed itself to provide support necessary to those working in this field. This is achieved through an extensive collaboration with ...

Synageva BioPharma Corp.

Synageva BioPharma Corp. is dedicated to discovering, developing and commercializing therapies for patients with rare conditions and unmet medical need. The Company has developed a pipeline of novel therapeutics for under-served populations and has assembled a team with a proven record of bringing orphan therapies to patients. Additionally, Synageva is ...

Array BioPharma

Array BioPharma is a drug discovery company inventing new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use the Array Discovery Platform, our integrated set of drug discovery technologies, to invent novel small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of pro...

AOP Orphan Pharmaceuticals AG

AOP Orphan is a multinational company with headquarters in Vienna, Austria, focusing on clinical research, development and distribution of medicines for rare and complex diseases. The company also provides individualized and customized services to meet and accommodate the needs of physicians and patients across Europe, the Middle East & Asia. Currently AOP...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (IgPO) to treat adult and juvenile rheumatoid arthritis, crippling diseases that affect more than 2.1 million people in the United States.Upon successful completion of this goal, Protein Therapeutics wil...

Devonian Health Group Inc.

Devonian Health Group Inc. is a late stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopi...

EXMOOR PHARMA CONCEPTED LTD

Exmoor pharma concept is a small friendly and innovate consultancy,specialising in biopharma and secondary pharma and helping our clients to develop their facilities and manufacturing strategies.This site describes our team,our project experience,our approuch and the services we offer.

Alizyme plc

Alizyme is a speciality biopharmaceutical development company, based in Cambridge, UK. We are focused on developing products for the treatment and management of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and motility, such as irritable bowel syndrome, of obesity and related diseases, such as diabetes, and of the gastrointestinal side effects of cancer therapy, s...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-biopharma.com.

Cureveda LLC

Cureveda LLC was co-founded in 2010 by Johns Hopkins Bloomberg School of Public Health faculty members Shyam Biswal and Rajesh Thimmulappa together with Christy Wyskiel. The company is focused on the discovery, development and commercialization of drugs for the treatment of inflammatory, autoimmune and neurogenerative diseases. Cureveda is developing Nrf2 ...

SAFE-BioPharma Association, LLC

As part of the National Health Information Sharing and Analysis Center (NH-ISAC), SAFE-BioPharma Association, LLC [www.safe-biopharma.org] provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries.

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has two products in late stage clinical development. FluDaseTM is a first-in-class broad-spectrum investigational therapeutic agent to treat all forms of influenza, including pandemic...

Pediatrix Medical Group, Inc.

Taking great care of our patients.Looking back, it’s hard to believe what started as a two-physician pediatric subspecialty practice in Broward County, Florida became the modern Pediatrix Medical Group. But this ordinary business arrangement initiated some extraordinary approaches to clinical practice management and patient care. We linked pediatric and obstetric sub-specialists to one another s...


More From BioPortfolio on "Innovate Biopharma Pediatric Ulcerative Colitis Drug Granted Orphan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks